Literature DB >> 20554773

Functional properties of the human cytomegalovirus IE86 protein required for transcriptional regulation and virus replication.

Siabhon M Harris1, Brady Bullock, Elizabeth Westgard, Hua Zhu, Richard M Stenberg, Julie A Kerry.   

Abstract

The human cytomegalovirus (HCMV) IE86 protein is essential for HCMV replication due to its ability to transactivate critical viral early promoters. In the current study, we performed a comprehensive mutational analysis between amino acids (aa) 535 and 545 of IE86 and assessed the impact of these mutations on IE86-mediated transcriptional activation. Using transient assays and complementing analysis with recombinant HCMV clones, we show that single amino acid mutations differentially impair the ability of IE86 to mediate transactivation of essential early gene promoters. The conserved tyrosine at amino acid 544 is critical for activation of the UL54 promoter in vitro and in the context of the viral genome. In contrast, mutation of the proline at position 535 disrupted activation of the UL54 promoter in transient assays but displayed activity similar to that of wild-type (WT) IE86 when assessed in the genomic context. To examine the underlying mechanism of this differential effect, glutathione S-transferase (GST) pulldown assays were performed, revealing that Y544 is critical for binding to the TATA binding protein (TBP), suggesting that this interaction is likely necessary for the ability of IE86 to activate the UL54 promoter. In contrast, mutation of either P535 or Y544 disrupted activation of the UL112-113 promoter both in vitro and in vivo, suggesting that interaction with TBP is not sufficient for IE86-mediated activation of this early promoter. Together, these studies demonstrate that IE86 activates early promoters by distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554773      PMCID: PMC2919014          DOI: 10.1128/JVI.00327-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein.

Authors:  Julie A Heider; Yongjun Yu; Thomas Shenk; James C Alwine
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene.

Authors:  Dong Yu; Gregory A Smith; Lynn W Enquist; Thomas Shenk
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Transactivation activity of the human cytomegalovirus IE2 protein occurs at steps subsequent to TATA box-binding protein recruitment.

Authors:  J M Kim; Y Hong; K T Jeang; S Kim
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

5.  Identification and characterization of novel murine cytomegalovirus M112-113 (e1) gene products.

Authors:  Gina M Ciocco-Schmitt; Zaruhi Karabekian; Earl W Godfrey; Richard M Stenberg; Ann E Campbell; Julie A Kerry
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

6.  Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes.

Authors:  A Marchini; H Liu; H Zhu
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Strain variations in single amino acids of the 86-kilodalton human cytomegalovirus major immediate-early protein (IE2) affect its functional and biochemical properties: implications of dynamic protein conformation.

Authors:  M Inmaculada Barrasa; Noam Harel; Yongjun Yu; James C Alwine
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Construction of a rationally designed human cytomegalovirus variant encoding a temperature-sensitive immediate-early 2 protein.

Authors:  Julie A Heider; Wade A Bresnahan; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

9.  Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection.

Authors:  Anja Berndt; Heike Hofmann-Winkler; Nina Tavalai; Gabriele Hahn; Thomas Stamminger
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

10.  The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF.

Authors:  L A Bryant; P Mixon; M Davidson; A J Bannister; T Kouzarides; J H Sinclair
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

View more
  3 in total

1.  The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Giulia Muratore; Serena Massari; Maria Elena Terlizzi; Oriana Tabarrini; Giorgio Gribaudo; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 2.  Early inhibitors of human cytomegalovirus: state-of-art and therapeutic perspectives.

Authors:  Beatrice Mercorelli; David Lembo; Giorgio Palù; Arianna Loregian
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

Review 3.  The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis.

Authors:  Carmen Valentina Cristescu; Sophie Alain; Simona Maria Ruță
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.